Lipidomics is an emerging biomedical research discipline, which involves complex lipidome analysis. Lipidome is a quantitative and comprehensive description of a set of lipid species in an organism. Lipidomics involves system level quantitation and identification of several number of networks and pathways of cellular lipids and interaction with other proteins and moieties. Increase in need for accurate disease diagnosis, growth in demand for personalized medicine, technological advancements in field of lipidomics and huge investments from the public and private sectors for R&D activities are anticipated to fuel the market growth over the forecast period. The research includes detailed information on developing trends, market drivers, development opportunities, and market restraints that may affect the industry’s market dynamics. It includes a product, application, and competition analysis, as well as an in-depth examination of the market segments. Moreover, wide range of applications of lipidomics, increase in the prevalence of target diseases such as cancers, and increase in scope of clinical trials and toxicological studies are expected to boost market. However, stringent regulatory guidelines, unavailability of advanced instruments, lack of technology adoption, dearth professional researchers, high cost for R&D activities, and issues with data examination and processing are expected to hamper the growth of lipidomics services over the forecast period.
In July 2020, Croda International Plc (‘Croda’) confirms that, following approval from the US regulatory authorities, it has now successfully completed the acquisition of Avanti Polar Lipids, Inc., a leader in drug delivery systems for next generation pharmaceuticals.
In March 2020, Waters Corporation and the University of Tokyo are collaborating on a lipidomics research project to provide a clearer picture of what it means to be healthy. Led by Prof. Yoshiya Oda from the Graduate School of Medicine at the University of Tokyo, the study is exploring the relationship between lipids and human health through the application of ion mobility-mass spectrometry (IMS-MS) technology.